Peptidomimetics Therapeutics for Retinal Disease.

Parsons, Dylan E; Lee, Soo Hyeon; Sun, Young Joo; Velez, Gabriel; Bassuk, Alexander G; Smith, Mark; Mahajan, Vinit B

Parsons, Dylan E; Lee, Soo Hyeon; Sun, Young Joo; Velez, Gabriel; Bassuk, Alexander G; Smith, Mark; Mahajan, Vinit B.

Afiliação

Parsons DE; Molecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, USA.
Lee SH; Stanford ChEM-H Medicinal Chemistry Knowledge Center, Stanford University, Palo Alto, CA 94305, USA.
Sun YJ; Molecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, USA.
Velez G; Molecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, USA.
Bassuk AG; Molecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, USA.
Smith M; Medical Scientist Training Program, University of Iowa, Iowa City, IA 52242, USA.
Mahajan VB; Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA.

Biomolecules ; 11(3)2021 02 24.

Article em En | MEDLINE | ID: mdl-33668179

Assuntos

Peptidomiméticos; Doenças Retinianas/metabolismo; Animais; Composição de Medicamentos; Sistemas de Liberação de Medicamentos; Humanos; Retina/metabolismo

Palavras-chave

drug delivery; formulation; peptidomimetics; pharmacokinetics; retina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Peptidomiméticos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google